| Total Revenue | | 31 | 23 |
| Cost of Goods Sold Incl. D&A | | 12 | 11 |
| Gross Profit | | 19 | 12 |
| Selling, General and Administrative Excl. Other | | 133 | 31 |
| Research and Development | | 405 | 122 |
| Other Operating Expense | | 11 | 12 |
| Operating Income | | -530 | -153 |
| Interest Expense | | 0 | 0 |
| Unusual Expense | | — | — |
| Non-Operating Income (Expense) | | 38 | -9 |
| Net Income Before Taxes | | -568 | -144 |
| Income Taxes | | 0 | 0 |
| Consolidated Net Income | | -72 | -144 |
| Net Income From Continuing Operations | | -568 | -144 |
| Net Income | | -72 | -144 |
| EPS (Recurring) | | -2.15 | -4.16 |
| EPS (Basic, Before Extraordinaries) | | -2.15 | -4.16 |
| EPS (Diluted) | | -2.15 | -4.16 |
| EBITDA | | -538 | -112 |
| Other After Tax Adjustments | | — | — |
| Stock Option Compensation Expense | | — | — |
| Price To Earnings Ratio | | — | — |
| Price To Sales Ratio | | — | — |
| Gross Margin | | 61.29 | 52.17 |
| Operating Margin | | -1,709.68 | -665.22 |
| Net Margin | | -232.26 | -626.09 |
| Shares Outstanding | | 33 | 35 |
| Market Capitalization | | — | — |
| Operating Lease Expense | | — | — |
